Skip to main content

Advertisement

Table 1 Clinical information of patients

From: Hematopoietic stem cell transplantation induces immunologic tolerance in renal transplant patients via modulation of inflammatory and repair processes

Variable Kidney transplantation (n = 8) Combined hematopoietic stem cells and kidney transplantation (n = 4)
Recipient gender, n (% female) 37.50 % 0
Recipient age, mean ± SD 38.00 ± 12.70 33.00 ± 2.16
Creatinine at Tx [μmol/L], mean ± SD 2105.75 ± 318.69 1569.25 ± 458.77
Creatinine at one month after Tx [μmol/L], mean ± SD 127.00 ± 47.65 110.50 ± 10.89
Hemoglobin at Tx [g/L] 102 ± 32.32 104.00 ± 16.51
Systolic blood pressure [mmHg], mean ± SD 122.25 ± 8.97 140.00 ± 28.28
Diastolic blood pressure [mmHg], mean ± SD 78.75 ± 6.41 90.00 ± 20.00
PRA > 20 % (%) 0 25 %
HLA-mismatches, median (range) 1.5(0–4) 0.5(0–3)
Immunosuppressive treatment FK506/Pred/MMF, n (%) CsA/Pred/MMF, n (%) 75 % 25 % 75 % 25 %
Post-Tx immunologic rejection in half year,n (%) 37.5 % 0
  1. Tx, Transplantation; HLA, Human leukocyte antigen; PRA, Panel reactive antibody; FK506, Tacrolimus; Pred, Prednisone; MMF, Mycophenolate; CsA, Cyclosporine.